Cargando…

Heterogeneity in functional genetic screens: friend or foe?

Functional genetic screens to uncover tumor-intrinsic nodes of immune resistance have uncovered numerous mechanisms by which tumors evade our immune system. However, due to technical limitations, tumor heterogeneity is imperfectly captured with many of these analyses. Here, we provide an overview of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vredevoogd, David W., Peeper, Daniel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312307/
https://www.ncbi.nlm.nih.gov/pubmed/37398651
http://dx.doi.org/10.3389/fimmu.2023.1162706
_version_ 1785066909034610688
author Vredevoogd, David W.
Peeper, Daniel S.
author_facet Vredevoogd, David W.
Peeper, Daniel S.
author_sort Vredevoogd, David W.
collection PubMed
description Functional genetic screens to uncover tumor-intrinsic nodes of immune resistance have uncovered numerous mechanisms by which tumors evade our immune system. However, due to technical limitations, tumor heterogeneity is imperfectly captured with many of these analyses. Here, we provide an overview of the nature and sources of heterogeneity that are relevant for tumor-immune interactions. We argue that this heterogeneity may actually contribute to the discovery of novel mechanisms of immune evasion, given a sufficiently large and heterogeneous set of input data. Taking advantage of tumor cell heterogeneity, we provide proof-of-concept analyses of mechanisms of TNF resistance. Thus, consideration of tumor heterogeneity is imperative to increase our understanding of immune resistance mechanisms.
format Online
Article
Text
id pubmed-10312307
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103123072023-07-01 Heterogeneity in functional genetic screens: friend or foe? Vredevoogd, David W. Peeper, Daniel S. Front Immunol Immunology Functional genetic screens to uncover tumor-intrinsic nodes of immune resistance have uncovered numerous mechanisms by which tumors evade our immune system. However, due to technical limitations, tumor heterogeneity is imperfectly captured with many of these analyses. Here, we provide an overview of the nature and sources of heterogeneity that are relevant for tumor-immune interactions. We argue that this heterogeneity may actually contribute to the discovery of novel mechanisms of immune evasion, given a sufficiently large and heterogeneous set of input data. Taking advantage of tumor cell heterogeneity, we provide proof-of-concept analyses of mechanisms of TNF resistance. Thus, consideration of tumor heterogeneity is imperative to increase our understanding of immune resistance mechanisms. Frontiers Media S.A. 2023-06-16 /pmc/articles/PMC10312307/ /pubmed/37398651 http://dx.doi.org/10.3389/fimmu.2023.1162706 Text en Copyright © 2023 Vredevoogd and Peeper https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Vredevoogd, David W.
Peeper, Daniel S.
Heterogeneity in functional genetic screens: friend or foe?
title Heterogeneity in functional genetic screens: friend or foe?
title_full Heterogeneity in functional genetic screens: friend or foe?
title_fullStr Heterogeneity in functional genetic screens: friend or foe?
title_full_unstemmed Heterogeneity in functional genetic screens: friend or foe?
title_short Heterogeneity in functional genetic screens: friend or foe?
title_sort heterogeneity in functional genetic screens: friend or foe?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312307/
https://www.ncbi.nlm.nih.gov/pubmed/37398651
http://dx.doi.org/10.3389/fimmu.2023.1162706
work_keys_str_mv AT vredevoogddavidw heterogeneityinfunctionalgeneticscreensfriendorfoe
AT peeperdaniels heterogeneityinfunctionalgeneticscreensfriendorfoe